urse led cognitive enhancement strategy to improve quality of life of dementia patient.
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: F028- Dementia in other diseases classified elsewhereHealth Condition 2: F01-F09- Mental disorders due to known physiological conditions
- Registration Number
- CTRI/2024/07/071704
- Lead Sponsor
- SUCHISMITA PAHANTASINGH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All mild to moderate level of dementia patient and must have completed six sessions of planned intervention.
Exclusion Criteria
Patient with severe dementia,other psychotic symptoms and those who have undergone similar form of cognitive enhancement programme or therapy or any other trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cognitive enhancement in dementia patients through nurse-led interventions?
How does a nurse-led cognitive enhancement strategy compare to standard-of-care treatments for F028 and F01-F09 dementia subtypes?
Which biomarkers are associated with improved cognition and quality of life in response to nurse-led cognitive interventions for dementia?
What are the potential adverse events and management strategies for nurse-led cognitive enhancement programs in dementia patients?
Are there any related compounds or combination therapies that enhance cognitive function in F028 and F01-F09 dementia classifications?